Pharmacovigilance Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
The study predicts the short term and long term trends that can shape up the future of the Pharmacovigilance market including the COVID-19 pandemic implications for Pharmacovigilances industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.
The Pharmacovigilance market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Pharmacovigilance Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Pharmacovigilance market forecast and Pharmacovigilance market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023- 2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Pharmacovigilance market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Pharmacovigilance industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Pharmacovigilance market share in developed countries.
Scope of the research-
Global Pharmacovigilance Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By Clinical Trial Phase
Preclinical
Phase I
Phase II
Phase III
Phase IV
Global Pharmacovigilance Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By Service Provider
In House
Contract & Outsourcing
Global Pharmacovigilance Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By Reporting Type
Trageted Spontaneous Reporting
Cohort Event Monitoring
Spontaneous Reporting
Intensified ADR Reporting
EHR Mining
Global Pharmacovigilance Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By End User including
Hospitals and Clinics
Pharamaceuticals Companies
Others
Top Companies Operating in Pharmacovigilance market include- Accenture , ArisGlobal , BioClinica , Capgemini , Clinquest Group , Cognizant , Foresight Group International AG , IBM Corporation , ICON PLC , iMEDGlobal
The Pharmacovigilance market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Pharmacovigilance Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Pharmacovigilance market forecast and Pharmacovigilance market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023- 2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Pharmacovigilance market opportunities, underlying market factors, demographic and economic factors, market developments and others.
Pharmacovigilance industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Pharmacovigilance market share in developed countries.
Scope of the research-
Global Pharmacovigilance Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By Clinical Trial Phase
Preclinical
Phase I
Phase II
Phase III
Phase IV
Global Pharmacovigilance Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By Service Provider
In House
Contract & Outsourcing
Global Pharmacovigilance Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By Reporting Type
Trageted Spontaneous Reporting
Cohort Event Monitoring
Spontaneous Reporting
Intensified ADR Reporting
EHR Mining
Global Pharmacovigilance Testing Market is analyzed and forecast over the outlook period from 2023 to 2030 By End User including
Hospitals and Clinics
Pharamaceuticals Companies
Others
Top Companies Operating in Pharmacovigilance market include- Accenture , ArisGlobal , BioClinica , Capgemini , Clinquest Group , Cognizant , Foresight Group International AG , IBM Corporation , ICON PLC , iMEDGlobal
1. TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2. EXECUTIVE SUMMARY
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Pharmacovigilance Market- Key Findings, 2022
3. STRATEGIC IMPERATIVES ON GLOBAL PHARMACOVIGILANCE MARKET
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Pharmacovigilance Companies
4. GLOBAL PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030 TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY CLINICAL TRIAL PHASE
4.1 Preclinical
4.2 Phase I
4.3 Phase II
4.4 Phase III
4.5 Phase IV
5. GLOBAL PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030 TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY SERVICE PROVIDER
5.1 In House
5.2 Contract & Outsourcing
6. GLOBAL PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030 TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY REPORTING TYPE
6.1 Trageted Spontaneous Reporting
6.2 Cohort Event Monitoring
6.3 Spontaneous Reporting
6.4 Intensified ADR Reporting
6.5 EHR Mining
7. GLOBAL PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030 TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY END USER
7.1 Hospitals and Clinics
7.2 Pharamaceuticals Companies
7.3 Others
8 ASIA PACIFIC PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
8.1 Leading Pharmacovigilance Types contributing to Asia Pacific market
8.2 Top Applications contributing to Asia Pacific Pharmacovigilance
8.3 Top countries contributing to Asia Pacific Pharmacovigilance
9 EUROPE PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
9.1 Leading Pharmacovigilance Types contributing to Europe market
9.2 Top Applications contributing to Europe Pharmacovigilance
9.3 Top countries contributing to Europe Pharmacovigilance
10 NORTH AMERICA PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
10.1 Leading Pharmacovigilance Types contributing to North America market
10.2 Top Applications contributing to North America Pharmacovigilance
10.3 Top countries contributing to North America Pharmacovigilance
11 SOUTH AND CENTRAL AMERICA PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
11.1 Leading Pharmacovigilance Types contributing to South and Central America market
11.2 Top Applications contributing to South and Central America Pharmacovigilance
11.3 Top countries contributing to South and Central America Pharmacovigilance
12 MIDDLE EAST AFRICA PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
12.1 Leading Pharmacovigilance Types contributing to Middle East Africa market
12.2 Top Applications contributing to Middle East Africa Pharmacovigilance
12.3 Top countries contributing to Middle East Africa Pharmacovigilance
13 BUSINESS PROFILES OF LEADING COMPANIES
13.1 Business Description, SWOT and Financial Analysis of Companies in Pharmacovigilance market
13.2 Accenture
13.3 ArisGlobal
13.4 BioClinica
13.5 Capgemini
13.6 Clinquest Group
13.7 Cognizant
13.8 Foresight Group International AG
13.9 IBM Corporation
13.10 ICON PLC
13.11 iMEDGlobal
14 RECENT INDUSTRY DEVELOPMENTS
15 APPENDIX
15.1 OGAnalysis Expertise
15.2 Sources and Methodology
15.3 Contacts
1.1 List of Tables
1.2 List of Figures
2. EXECUTIVE SUMMARY
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Pharmacovigilance Market- Key Findings, 2022
3. STRATEGIC IMPERATIVES ON GLOBAL PHARMACOVIGILANCE MARKET
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Pharmacovigilance Companies
4. GLOBAL PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030 TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY CLINICAL TRIAL PHASE
4.1 Preclinical
4.2 Phase I
4.3 Phase II
4.4 Phase III
4.5 Phase IV
5. GLOBAL PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030 TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY SERVICE PROVIDER
5.1 In House
5.2 Contract & Outsourcing
6. GLOBAL PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030 TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY REPORTING TYPE
6.1 Trageted Spontaneous Reporting
6.2 Cohort Event Monitoring
6.3 Spontaneous Reporting
6.4 Intensified ADR Reporting
6.5 EHR Mining
7. GLOBAL PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030 TESTING MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY END USER
7.1 Hospitals and Clinics
7.2 Pharamaceuticals Companies
7.3 Others
8 ASIA PACIFIC PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
8.1 Leading Pharmacovigilance Types contributing to Asia Pacific market
8.2 Top Applications contributing to Asia Pacific Pharmacovigilance
8.3 Top countries contributing to Asia Pacific Pharmacovigilance
9 EUROPE PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
9.1 Leading Pharmacovigilance Types contributing to Europe market
9.2 Top Applications contributing to Europe Pharmacovigilance
9.3 Top countries contributing to Europe Pharmacovigilance
10 NORTH AMERICA PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
10.1 Leading Pharmacovigilance Types contributing to North America market
10.2 Top Applications contributing to North America Pharmacovigilance
10.3 Top countries contributing to North America Pharmacovigilance
11 SOUTH AND CENTRAL AMERICA PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
11.1 Leading Pharmacovigilance Types contributing to South and Central America market
11.2 Top Applications contributing to South and Central America Pharmacovigilance
11.3 Top countries contributing to South and Central America Pharmacovigilance
12 MIDDLE EAST AFRICA PHARMACOVIGILANCE MARKET VALUE OUTLOOK TO 2030
12.1 Leading Pharmacovigilance Types contributing to Middle East Africa market
12.2 Top Applications contributing to Middle East Africa Pharmacovigilance
12.3 Top countries contributing to Middle East Africa Pharmacovigilance
13 BUSINESS PROFILES OF LEADING COMPANIES
13.1 Business Description, SWOT and Financial Analysis of Companies in Pharmacovigilance market
13.2 Accenture
13.3 ArisGlobal
13.4 BioClinica
13.5 Capgemini
13.6 Clinquest Group
13.7 Cognizant
13.8 Foresight Group International AG
13.9 IBM Corporation
13.10 ICON PLC
13.11 iMEDGlobal
14 RECENT INDUSTRY DEVELOPMENTS
15 APPENDIX
15.1 OGAnalysis Expertise
15.2 Sources and Methodology
15.3 Contacts
